Firefly Neuroscience, Inc. (AIFF)
NASDAQ: AIFF · Real-Time Price · USD
0.697
+0.006 (0.84%)
At close: Feb 27, 2026, 4:00 PM EST
0.720
+0.022 (3.18%)
After-hours: Feb 27, 2026, 6:52 PM EST
Company Description
Firefly Neuroscience, Inc., a medical technology and artificial intelligence company, provides neuroscientific solutions that improve brain health outcomes for patients with mental illnesses and neurological disorders.
The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder.
It serves pharmaceutical companies and medical practitioners. Firefly Neuroscience, Inc. was founded in 2006 and is based in Kenmore, New York.
Firefly Neuroscience, Inc.
| Country | United States |
| Founded | 2006 |
| Industry | Software - Application |
| Sector | Technology |
| Employees | 13 |
| CEO | Greg Lipschitz |
Contact Details
Address: 1100 Military Road Kenmore, New York 14217 United States | |
| Phone | 888 237 6412 |
| Website | fireflyneuro.com |
Stock Details
| Ticker Symbol | AIFF |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0000803578 |
| CUSIP Number | 317970101 |
| ISIN Number | US3179701012 |
| Employer ID | 54-1167364 |
| SIC Code | 7372 |
Key Executives
| Name | Position |
|---|---|
| Greg Lipschitz | Chief Executive Officer and Director |
| David DeCaprio | President, Chief Operating Officer and Director |
| Paul Krzywicki CPA | Chief Financial Officer and Company Secretary |
| Gil Issachar | Chief Technology Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Feb 4, 2026 | 8-K | Current Report |
| Feb 3, 2026 | 424B5 | Filing |
| Jan 30, 2026 | SCHEDULE 13D/A | Filing |
| Dec 31, 2025 | SCHEDULE 13D/A | Filing |
| Dec 19, 2025 | 8-K | Current Report |
| Dec 9, 2025 | SCHEDULE 13D/A | Filing |
| Dec 5, 2025 | EFFECT | Notice of Effectiveness |
| Dec 3, 2025 | S-3 | Registration statement under Securities Act of 1933 |
| Nov 18, 2025 | S-8 | Securities to be offered to employees in employee benefit plans |
| Nov 17, 2025 | DRS | [Cover] Draft Registration Statement |